Fig. 1.

Immune responses after 2-dose inactivated SARS-CoV-2 vaccination in patients with chronic kidney disease. (A) Neutralization antibodies response. (B) anti-SARS-CoV-2 receptor-binding domain (RBD)-specific IgG response. (C) anti-RBD IgM response. (D) Neutralization antibody responses in patients on immunosuppression. (E) The correlations between neutralizing antibody response and eGFR. Antibody titers were presented as median (IQR: interquartile range). The thresholds for neutralization antibodies is represented by the dashed lines, with <2.0 classified as no response, <5.0 as low response, <15.0 as middle response, and >=15.0 as high response. CKD, chronic kidney disease; eGFR, estimated glomerular filtration rate.